GlassScriptPhysician profile
Aileen Marie Deamer
NPI 1164418265
$944.32
in general payments reported to CMS, 2019-2025
14 companies · $236 in 2025
The $236 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.98 · 2022: $84.55 · 2023: $245 · 2024: $365 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $847.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $846.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $210.15 | 2023-2025 | Sotyktu |
| Abbvie INC. | $164.57 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $135.12 | 2022-2025 | Winlevi, Absorica Ld |
| Leo Pharma INC. | $90.82 | 2022-2025 | Adbry, Anzupgo |
| Genzyme Corporation | $84.20 | 2023-2025 | |
| Janssen Biotech, INC. | $67.21 | 2025 | Tremfya |
| Amgen INC. | $41.49 | 2024 | Otezla |
| Novartis Pharmaceuticals Corporation | $33.74 | 2024-2025 | |
| Incyte Corporation | $28.78 | 2023 | Opzelura |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $22.71 | 2023 | Jublia |
| Pfizer INC. | $22.03 | 2024 | |
| Arcutis Biotherapeutics, INC. | $20.59 | 2024 | Zoryve |
| Dermavant Sciences, INC. | $15.43 | 2024 | Vtama |
| Organon LLC | $7.48 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aileen Deamer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.